Skip to main content
65°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dermata Therapeutics, Inc. - Common Stock
(NQ:
DRMA
)
0.7290
+0.0190 (+2.68%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dermata Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket
January 03, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 02, 2023
Via
Benzinga
Dow Falls 300 Points On Last Trading Session of 2022; S&P 500 Down 1%
December 30, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 300 points on Friday.
Via
Benzinga
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
November 10, 2022
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's Intraday Session
December 30, 2022
Via
Benzinga
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
December 30, 2022
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...
Via
Benzinga
Nasdaq Falls 100 Points; Dermata Therapeutics Shares Surge
December 30, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 100 points on Friday.
Via
Benzinga
Why Dermata Therapeutics Stock Is Trading 100% Higher Today
December 30, 2022
Dermata Therapeutics Inc (NASDAQ: DRMA) shares are trading higher by 101.10% to $0.40 Friday morning after the company requested to withdraw its registration on Form S-1 and said it does not intend to...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 30, 2022
Via
Benzinga
Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket
December 30, 2022
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to...
Via
Benzinga
Uxin, Heidrick & Struggles International And 3 Stocks To Watch Heading Into Friday
December 30, 2022
With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 29, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 16, 2022
Via
Benzinga
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
December 16, 2022
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 16, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 05, 2022
Via
Benzinga
Why Dermata Therapeutics Stock is Getting Obliterated
December 05, 2022
Dermata Therapeutics Inc (NASDAQ: DRMA) shares are trading lower after the company announced topline results from its DMT310 Phase 2 trial, which did not meet primary endpoints. What Else?
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
December 05, 2022
During Monday's session, 49 companies made new 52-week lows.
Via
Benzinga
Dermata Announces Topline Results from DMT310 Phase 2 Clinical Trial for the Treatment of Moderate-to-Severe Rosacea
December 05, 2022
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 15, 2022
Via
Benzinga
Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday
October 25, 2022
Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) climbed 62.4% to close at $0.39. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation.
Via
Benzinga
Why Vaxcyte Shares Are Trading Sharply Higher? Here Are 63 Stocks Moving In Monday's Mid-Day Session
October 24, 2022
Gainers Vaxcyte, Inc. (NASDAQ: PCVX) shares jumped 65% to $33.96 after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety,...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 21, 2022
Gainers Pulmatrix (NASDAQ:PULM) shares rose 11.9% to $4.3 during Wednesday's after-market session. The company's market cap stands at $14.5 million.
Via
Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
September 07, 2022
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
Via
Benzinga
Dermata to Present at the H.C. Wainwright 24th Annual Global Investment Conference
September 06, 2022
Via
ACCESSWIRE
Dermata to Participate in the Gilmartin Group Emerging Growth Company Showcase
August 24, 2022
Via
ACCESSWIRE
Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket
August 17, 2022
Gainers Hill International, Inc. (NYSE: HIL) shares rose 58.1% to $2.75 in pre-market trading after the company agreed to be acquired by Global Infrastructure Solutions Inc. for $2.85 per share.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 16, 2022
Via
Benzinga
Dermata Therapeutics: Q2 Earnings Insights
August 15, 2022
Dermata Therapeutics (NASDAQ:DRMA) reported its Q2 earnings results on Monday, August 15, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.